DEVICE GUIDE > Mechanical Thrombectomy/Thrombolysis

Company Name Product Name Sheath Size (F) Guidewire (inch) Working Length (cm) Mode of Operation CE Mark Indications
Acandis GmbH & Co. KG Aperio 1.9 F Thrombectomy Device 0.010–0.014 30 mm Thrombectomy device for the mechanical extraction of clots from cerebral vessels with a diameter > 2.0 mm and ≤ 4.0 mm Intended for use of restoration of the arterial flow for patients diagnosed with ischemic stroke due to large intracranial vessel occlusion (ie, internal carotid artery, M1 and M2 segments of the MCA); patients who fail intravenous thrombolytic therapy or who are ineligible for thrombolysis may be suited for treatment with the Aperio device
Acandis GmbH & Co. KG Aperio 3 F Thrombectomy System 0.010–0.014 40 mm Thrombectomy system (includes microcatheter) for the mechanical extraction of clots from cerebral vessels with a diameter > 2.0 mm and ≤ 4.0 mm Intended for use of restoration of the arterial flow for patients diagnosed with ischemic stroke due to large intracranial vessel occlusion (ie, internal carotid artery, M1 and M2 segments of the MCA); patients who fail intravenous thrombolytic therapy or who are ineligible for thrombolysis may be suited for treatment with the Aperio device
Argon Medical Devices, Inc. Cleaner 15 7 65, 135 Battery-operated, handheld drive unit initiates the mechanical rotation of an atraumatic, wall-contacting, 15-mm sinusoidal vortex wire for effective thrombus maceration Indicated for mechanical declotting and controlled and selective infusion of physician-specified fluids, including thrombolytics, in the peripheral vasculature; also indicated for mechanical declotting of native vessel dialysis fistulas and synthetic dialysis access grafts
Argon Medical Devices, Inc. Cleaner XT 6 65, 135 Battery-operated, handheld drive unit initiates the mechanical rotation of an atraumatic, wall-contacting, 9-mm sinusoidal vortex wire for effective thrombus maceration Indicated for mechanical declotting and controlled and selective infusion of physician-specified fluids, including thrombolytics, in the peripheral vasculature; also indicated for mechanical declotting of native vessel dialysis fistulas and synthetic dialysis access grafts
Boston Scientific Corporation AngioJet AVX Thrombectomy Set 6 0.035 50 High-velocity water jets enclosed in catheter utilize the Bernoulli principle for capture, microfragmentation, and removal Breaking apart and removing thrombus from AV access conduits ≥ 3 mm in diameter
Boston Scientific Corporation AngioJet Distaflex Thrombectomy Set 4 0.014 145 High-velocity water jets enclosed in catheter utilize the Bernoulli principle for capture, microfragmentation, and removal Removing thrombus in the treatment of patients with symptomatic coronary artery or saphenous vein graft lesions prior to balloon angioplasty or stent placement and use in breaking apart and removing thrombus from infrainguinal peripheral arteries ≥ 2 mm in diameter
Boston Scientific Corporation AngioJet Solent Dista Thrombectomy Set 4 0.014 145 High-velocity water jets enclosed in catheter utilize the Bernoulli principle for capture, microfragmentation, and removal (PowerPulse enabled) Breaking apart and removing thrombus from upper and lower extremity peripheral arteries ≥ 1.5 mm in diameter
Boston Scientific Corporation AngioJet Solent Omni Thrombectomy Set 6 0.035 120 High-velocity water jets enclosed in catheter utilize the Bernoulli principle for capture, microfragmentation, and removal (PowerPulse enabled) Breaking apart and removing thrombus from upper and lower extremity peripheral arteries, upper extremity peripheral veins, iliofemoral and lower extremity veins, and AV access conduits ≥ 3 mm in diameter
Boston Scientific Corporation AngioJet Solent Proxi Thrombectomy Set 6 0.035 90 High-velocity water jets enclosed in catheter utilize the Bernoulli principle for capture, microfragmentation, and removal (PowerPulse enabled) Breaking apart and removing thrombus from upper and lower extremity peripheral arteries, upper extremity peripheral veins, iliofemoral and lower extremity veins, and AV access conduits ≥ 3 mm in diameter
Boston Scientific Corporation AngioJet Spiroflex Thrombectomy Set 5 0.014 135 High-velocity water jets enclosed in catheter utilize the Bernoulli principle for capture, microfragmentation, and removal Removing thrombus in the treatment of patients with symptomatic coronary artery or saphenous vein graft lesions prior to balloon angioplasty or stent placement and use in breaking apart and removing thrombus from infrainguinal peripheral arteries ≥ 2 mm in diameter
Boston Scientific Corporation AngioJet SpiroflexVG Thrombectomy Set 6 0.014 135 High-velocity water jets enclosed in catheter utilize the Bernoulli principle for capture, microfragmentation, and removal Removing thrombus in the treatment of patients with symptomatic coronary artery or saphenous vein graft lesions prior to balloon angioplasty or stent placement and use in breaking apart and removing thrombus from infrainguinal peripheral arteries ≥ 3 mm in diameter
Boston Scientific Corporation AngioJet Ultra PE Thrombectomy Set 6 0.035 120 High-velocity water jets enclosed in catheter utilize the Bernoulli principle for capture, microfragmentation, and removal Breaking apart and removing thrombus from main pulmonary and lobar arteries ≥ 6 mm in diameter
Boston Scientific Corporation AngioJet XMI Thrombectomy Set 4 0.014 135 High-velocity water jets enclosed in catheter utilize the Bernoulli principle for capture, microfragmentation, and removal Removing thrombus in the treatment of patients with symptomatic coronary artery or saphenous vein graft lesions prior to balloon angioplasty or stent placement and use in breaking apart and removing thrombus from infrainguinal peripheral arteries ≥ 2 mm in diameter
Boston Scientific Corporation AngioJet ZelanteDVT Thrombectomy Set 8 0.035 105 High-velocity water jets enclosed in catheter utilize the Bernoulli principle for capture, microfragmentation, and removal (PowerPulse enabled) Intended for use with the AngioJetUltra Console to break apart and remove thrombus, including DVT, from: Iliofemoraland lower extremity veins ≥ 6 mm in diameter and upper extremity peripheral veins ≥ 6 mm in diameter; the ZelanteDVT Thrombectomy Set is also intended for use with the AngioJet Ultra Power Pulse technique for the controlled and selective infusion of physician specified fluids, including thrombolytic agents, into the peripheral vascular system
Codman Neuro (Johnson & Johnson) ReVive SE Thrombectomy Device 5 or larger 205 Mechanical thrombectomy (stent retriever) Indicated to restore blood flow in patients with acute ischemic stroke secondary to intracranial occlusive vessel disease by providing temporary bypass across the occlusion and/or by the nonsurgical removal of emboli and thrombi; it may be used with aspiration and with the injection or infusion of contrast media and other fluids; the close-ended basket captures clots and large fragments
Control Medical Technology Aspire Aspirator Mechanical aspirator High-performace aspiration pump and drive unit to improve aspiration performance
Ekos Corporation, a BTG International group company EkoSonic Endovascular System 6 0.035 106 catheter length (treatment areas: 6, 12, 18, 24, 30, 40, 50), 135 catheter length (treatment areas: 12, 30, 40, 50) The treatment offers a minimally invasive system for the acceleration of thrombus dissolution; the ultrasonic core generates a localized acoustic field that targets the entire thrombus; this greatly accelerates lytic dispersion by driving the drug deeper into the clot and unwinding the fibrin to expose plasminogen receptor sites Intended for the treatment of pulmonary embolism patients with ≥ 50% clot burden in one or both main pulmonary arteries or lobar pulmonary arteries, and evidence of right heart dysfunction based on right heart pressures (mean pulmonary artery pressure ≥ 25 mm Hg) or echocardiographic evaluation; also intended for controlled and selective infusion of physician specified fluids, including thrombolytics, into the peripheral vasculature; contraindications: not designed for peripheral vasculature dilation purposes
Invamed Mantis 7 90 Battery-operated, handheld drive unit initiates the mechanical rotation of an atraumatic unique loop shape with aspiration DVT pharmacomechanical declotting and controlled and selective infusion of physician-specified fluids, including thrombolytics, in the peripheral vasculature; double engine volume, low and high speed options; hydrophilic tip
Invamed Reya Thrombectomy 6 65–135 Both mechanical and thrombolytic treatment; no capital equipment DVT pharmacomechanical declotting and controlled and selective infusion of physician-specified fluids, including thrombolytics, in the peripheral vasculature; double engine volume, low speed and high speed options; hydrophilic tip
Invamed Reya Vortex 4 0.035 200 Endovascular pharmocomechanical thrombectomy system intended for controlled and selective infusion of physician-specified thrombolytics into the clotted vessel Intended for controlled and selective infusion of physician-specified fluids, including thrombolytics, into the peripheral vasculature; all therapeutic agents utilized with the Reya Vortex system should be fully prepared and used according to the instructions for use of the specific therapeutic agent; Vortex system has an interior coil system that resonates with fluid infusion, which causes a vibration effect; mechanical vibration waves helps the thrombolytic drug to thin the fibrin, increase porosity, push drug deep inside the thrombus; for PE and DVT
Invamed Viper 5 0.035 200 Designed for controlled infusion of tPA along with mechanical vibrations Over the guidewire system and 200 cm catheter length allows safe access to closed target vessels including pulmonary artery in PE cases
Medtronic Trellis 8 Peripheral Infusion System 8 0.035 80, 120 Intended for controlled and selective infusion of physician-specified fluids, including thrombolytics, into the peripheral vasculature
Penumbra Europe GmbH Indigo System Catheter CAT3, CAT5, CAT6, and CAT8 3.4–8 0.014–0.038 Indigo catheter lengths: 85–150 Separator-assisted mechanical extraction of thrombus/debris with constant vacuum aspiration Intended for the removal of fresh, soft emboli and thrombi from vessels of the peripheral arterial and venous systems
Penumbra Europe GmbH Indigo System Separator SEP3, SEP5, SEP6, and SEP8 Indigo separator lengths: 150–190 Separator-assisted mechanical extraction of thrombus/debris with constant vacuum aspiration Intended for the removal of fresh, soft emboli and thrombi from vessels of the peripheral arterial and venous systems
Penumbra Europe GmbH Penumbra System Reperfusion Catheter ACE, 5MAX, 4MAX, 3MAX, 026 6 (ACE and 5MAX require 8-F short sheath or 6-F long sheath) 0.014–0.016 Reperfusion catheter lengths: 132, 139, 150, 153 Direct aspiration and Separator-assisted clot debulking if needed Intended for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease within 8 hours of symptom onset
Penumbra Europe GmbH Penumbra System Separator and Separator Flex 5MAX, 4MAX, 3MAX, 026 Separator and Separator Flex length: 175–200 Separator-assisted clot debulking, if needed Intended for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease within 8 hours of symptom onset
Penumbra Europe GmbH Separator 3D 6 (long sheath [Neuron MAX]) 0.020 200 (delivery wire; compatible with Velocity Delivery Microcatheter [160 cm] and 3MAX Reperfusion Catheter [153 cm]) A revascularization device that offers a technologically-advanced structure designed to successfully treat large vessel occlusion in combination with ACE Reperfusion catheters; provides maximum clot capture capability through four intraluminal chambers and is optimized for use with aspiration delivered by ACE catheters Intended for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral [M1 and M2 segments], basilar, and vertebral arteries) within 8 hours of symptom onset
phenox GmbH Preset Lite Thrombectomy Device 0.0165 inch (ID) 180 cm (insertion wire) Introduced into the target vessel through a suitable microcatheter and deployed inside the thrombus or distal to the thrombus; after complete deployment the slow withdrawal of the instrument occurs under continuous aspiration via the guiding catheter or aspiration catheter Designed for mechanical clot retrieval from intracranial arteries as acute ischemic stroke treatment for patients who are ineligible for intravenous thrombolysis or for patients who failed thrombolysis therapy and as a supplement treatment of an initiated thrombolysis therapy
phenox GmbH Preset Thrombectomy Device 0.021 inch (ID) 180 cm (insertion wire) Introduced into the target vessel through a suitable microcatheter and deployed inside the thrombus or distal to the thrombus; after complete deployment the slow withdrawal of the instrument occurs under continuous aspiration via the guiding catheter or aspiration catheter Designed for mechanical clot retrieval from intracranial arteries as acute ischemic stroke treatment for patients who are ineligible for intravenous thrombolysis or for patients who failed thrombolysis therapy and as a supplement treatment of an initiated thrombolysis therapy
Straub Medical AG Aspirex S 6, 8 0.018 110 Aspirex S catheters in combination with the Straub Medical Drive System (REF SRS-Set/80300) are intended for the percutaneous transluminal removal of fresh thrombotic or thromboembolic material from blood vessels outside the cardiopulmonary, coronary, and cerebral circulations Native blood vessels or vessels fitted with stents, stent grafts, or native or artificial bypasses outside the cardiopulmonary, coronary, and cerebral circulations
Straub Medical AG Aspirex S 10 0.025 110 Aspirex S catheters in combination with the Straub Medical Drive System (REF SRS-Set/80300) are intended for the percutaneous transluminal removal of fresh thrombotic or thromboembolic material from blood vessels outside the cardiopulmonary, coronary, and cerebral circulations Native blood vessels or vessels fitted with stents, stent grafts, or native or artificial bypasses outside the cardiopulmonary, coronary, and cerebral circulations
Straub Medical AG Aspirex S 8 0.018 85 Aspirex S catheters in combination with the Straub Medical Drive System (REF SRS-Set/80300) are intended for the percutaneous transluminal removal of fresh thrombotic or thromboembolic material from blood vessels outside the cardiopulmonary, coronary, and cerebral circulations Native blood vessels or vessels fitted with stents, stent grafts, or native or artificial bypasses outside the cardiopulmonary, coronary, and cerebral circulations
Straub Medical AG Aspirex S 6 0.018 135 Aspirex S catheters in combination with the Straub Medical Drive System (REF SRS-Set/80300) are intended for the percutaneous transluminal removal of fresh thrombotic or thromboembolic material from blood vessels outside the cardiopulmonary, coronary, and cerebral circulations Native blood vessels or vessels fitted with stents, stent grafts, or native or artificial bypasses outside the cardiopulmonary, coronary and cerebral circulations
Straub Medical AG Rotarex S 6 0.018 135 Rotarex S catheters in combination with the Straub Medical Drive System (REF SRS-Set/80300) are intended for the percutaneous transluminal removal of thrombotic, thromboembolic and atherothrombotic material from fresh, subacute and chronic occlusions of blood vessels outside the cardiopulmonary, coronary, and cerebral circulations Native blood vessels or vessels fitted with stents, stent grafts, or native or artificial bypasses outside the cardiopulmonary, coronary, and cerebral circulations
Straub Medical AG Rotarex S 6, 8 0.018 110 Rotarex S catheters in combination with the Straub Medical Drive System (REF SRS-Set/80300) are intended for the percutaneous transluminal removal of thrombotic, thromboembolic and atherothrombotic material from fresh, subacute and chronic occlusions of blood vessels outside the cardiopulmonary, coronary, and cerebral circulations Native blood vessels or vessels fitted with stents, stent grafts, or native or artificial bypasses outside the cardiopulmonary, coronary, and cerebral circulations
Straub Medical AG Rotarex S 10 0.025 85 Rotarex S catheters in combination with the Straub Medical Drive System (REF SRS-Set/80300) are intended for the percutaneous transluminal removal of thrombotic, thromboembolic and atherothrombotic material from fresh, subacute and chronic occlusions of blood vessels outside the cardiopulmonary, coronary, and cerebral circulations Native blood vessels or vessels fitted with stents, stent grafts, or native or artificial bypasses outside the cardiopulmonary, coronary, and cerebral circulations
Straub Medical AG Rotarex S 8 0.018 85 Rotarex S catheters in combination with the Straub Medical Drive System (REF SRS-Set/80300) are intended for the percutaneous transluminal removal of thrombotic, thromboembolic and atherothrombotic material from fresh, subacute and chronic occlusions of blood vessels outside the cardiopulmonary, coronary, and cerebral circulations Native blood vessels or vessels fitted with stents, stent grafts or native or artificial bypasses outside the cardiopulmonary, coronary, and cerebral circulations
Stryker Merci Retrieval System: X6 (3–1.5-mm diameter), L4 (2-mm diameter), L5 (2.5-mm diameter), L6 (2.7-mm diameter), V 2.0 Soft (2-mm diameter), V 2.0 Firm (2-mm diameter), V 2.5 Soft (2.5-mm diameter), V 2.5 Firm (2.5-mm diameter), V 3.0 Soft (3-mm diameter), V 3.0 Firm (3-mm diameter) 8, 9 (balloon guide catheter) 0.014 Balloon guide 8 and 9 F (80 and 95); MC14X, MC18L, and MC18 Plus (150); retriever (180) Mechanical thrombectomy with aspiration and proximal flow arrest with balloon guiding catheter Restoring blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke; patients who are ineligible for IV t-PA or who fail IV t-PA therapy are candidates for treatment; retrieval of foreign bodies misplaced during interventional radiological procedures in the neuro, peripheral, and coronary vasculature
Stryker Trevo ProVue 5 (minimum); recommend 8 or 9 balloon guide catheters 0.014 Trevo Pro 18 Microcatheter 150-cm effective length; TrevoPro Delivery Wire 180 cm Mechanical thrombectomy; Trevo ProVue Retriever is the first fully visible device with Stentriever technology which allows physicians to view placement and strut interaction with the clot Indicated for use to restore blood flow in the neurovasculature by removing thrombus for the treatment of acute ischemic stroke to reduce disability in patients with a persistent, proximal anterior circulation, large vessel occlusion, and smaller core infarcts who have first received IV t-PA; endovascular therapy with the device should start within 6 hours of symptom onset; intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke within 8 hours of symptom onset; patients who are ineligible for IV t-PA or who fail IV t-PA therapy are candidates for treatment
Stryker Trevo ProVue Retriever Balloon guide catheter (8 or larger) or DAC (0.044 or larger) Trevo Pro 18 Microcatheter length 150 cm; Trevo ProVue Retriever total length 180 cm Mechanical thrombectomy; stent retriever Intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke within 8 hours of symptom onset; patients who are ineligible for treatment with IV t-PA or who fail IV t-PA therapy are candidates for treatment
Stryker Trevo XP ProVue Retriever 3 X 20 mm, 4 X 20 mm, 4 X 30 mm, 6 X 25 mm 5 (minimum); recommend 8 or 9 balloon guide catheters 0.014 Trevo XP ProVue Retriever: Trevo Pro 18 Microcatheter 150-cm effective length, Trevo Pro 14 Microcatheter 157-cm effective length, Excelsior XT-27 Microcatheter 150-cm effective length; Trevo XP Delivery Wire 180 cm Trevo XP ProVue Retriever: mechanical thrombectomy; the fourth generation stent retriever; tubular with 360º of large cells, designed to integrate and capture clot; it is fully visible under fluoroscopy to allow the physician to visual placement and strut interaction with the clot Indicated for use to restore blood flow in the neurovasculature by removing thrombus for the treatment of acute ischemic stroke to reduce disability in patients with a persistent, proximal anterior circulation, large vessel occlusion, and smaller core infarcts who have first received IV t-PA; endovascular therapy with the device should start within 6 hours of symptom onset; intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke within 8 hours of symptom onset; patients who are ineligible for IV t-PA or who fail IV t-PA therapy are candidates for treatment
Stryker Trevo XP ProVue Retrievier Balloon guide catheter (8 or larger) or DAC (0.044 or larger) Trevo Pro 18 Microcatheter length 150 cm; Trevo Pro 14 Mircrocatheter length 157 cm; Trevo XP ProVue Retriever total length 180 cm (4 mm) and 190 cm (3 mm) Mechanical thrombectomy; stent retriever Intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke within 8 hours of symptom onset; patients who are ineligible for treatment with IV t-PA or who fail IV t-PA therapy are candidates for treatment
Teleflex Arrow-Trerotola OTW PTD 7 0.025 65, 120 Battery-operated handheld unit rotates unique 9-mm fragmentation basket at 3,000 rpm, macerating clot to < 2 mm; basket can be deployed/withdrawn within catheter; deployed basket can be used to pull arterial plug Permits mechanical declotting of native arterio/venous fistula synthetic dialysis grafts in conjunction with the Arrow Rotator Drive Unit (PT-03000-R)
Teleflex Arrow-Trerotola PTD 5 65 Battery-operated handheld unit rotates unique 9-mm fragmentation basket at 3,000 rpm, macerating clot to < 2 mm; basket can be deployed/withdrawn within catheter; deployed basket can be used to pull arterial plug Permits mechanical declotting of native arterio/venous fistula synthetic dialysis grafts in conjunction with the Arrow Rotator Drive Unit (PT-03000-R)
Walk Vascular, LLC Jeti 8 OTW: 0.010–0.038 or none 100 Internal saline jet located just within catheter tip and aspiration To break up and remove thrombus and soft emboli

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.